我武生物
(300357)
| 流通市值：98.68亿 | | | 总市值：106.44亿 |
| 流通股本：4.85亿 | | | 总股本：5.24亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 514,164,898.85 | 252,840,950.04 | 1,062,404,471.43 | 853,360,357.81 |
| 营业总成本 | 303,034,492.56 | 149,929,001.8 | 635,510,347.27 | 459,695,071.95 |
| 其他经营收益 | | | | |
| 营业利润 | 244,113,967.21 | 133,093,069.95 | 438,417,461.01 | 397,697,295.47 |
| 利润总额 | 240,440,223.99 | 131,783,306.64 | 432,705,375 | 394,278,352.77 |
| 净利润 | 208,576,920.39 | 116,512,634.85 | 368,089,245.89 | 335,236,989.97 |
| 每股收益 | | | | |
| 其他综合收益 | -10,367.96 | -6,064.56 | -6,986.28 | -4,046.55 |
| 综合收益总额 | 208,566,552.43 | 116,506,570.29 | 368,082,259.61 | 335,232,943.42 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,806,905,199.42 | 1,764,421,583.53 | 1,761,246,105.52 | 1,772,325,445.94 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,271,143,127.4 | 1,171,840,975.02 | 1,136,148,176.16 | 1,120,888,431.3 |
| 资产总计 | 3,078,048,326.82 | 2,936,262,558.55 | 2,897,394,281.68 | 2,893,213,877.24 |
| 流动负债: | | | | |
| 流动负债合计 | 197,655,411.88 | 67,506,994.4 | 144,573,973.66 | 119,952,859.31 |
| 非流动负债: | | | | |
| 非流动负债合计 | 39,644,704.25 | 41,529,735.6 | 41,096,853.06 | 42,028,479.16 |
| 负债合计 | 237,300,116.13 | 109,036,730 | 185,670,826.72 | 161,981,338.47 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 2,754,356,032.24 | 2,738,678,310 | 2,619,452,220.07 | 2,635,739,108.73 |
| 股东权益合计 | 2,840,748,210.69 | 2,827,225,828.55 | 2,711,723,454.96 | 2,731,232,538.77 |
| 负债和股东权益合计 | 3,078,048,326.82 | 2,936,262,558.55 | 2,897,394,281.68 | 2,893,213,877.24 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 553,861,841.23 | 230,408,095.32 | 1,134,097,422.33 | 870,623,729.48 |
| 经营活动现金流出小计 | 364,353,992.89 | 175,358,955.76 | 710,901,675.72 | 583,732,651.97 |
| 经营活动产生的现金流量净额 | 189,507,848.34 | 55,049,139.56 | 423,195,746.61 | 286,891,077.51 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 634,736,455.95 | 304,589,685.88 | 1,105,085,213.76 | 744,697,126.87 |
| 投资活动现金流出小计 | 576,610,219.11 | 260,490,025.84 | 1,376,963,923.14 | 894,953,324.95 |
| 投资活动产生的现金流量净额 | 58,126,236.84 | 44,099,660.04 | -271,878,709.38 | -150,256,198.08 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 5,000,000 | 5,000,000 | 20,000,000 | 20,000,000 |
| 筹资活动现金流出小计 | 59,978,219.24 | 58,932,425.46 | 149,109,173.84 | 147,817,678.53 |
| 筹资活动产生的现金流量净额 | -54,978,219.24 | -53,932,425.46 | -129,109,173.84 | -127,817,678.53 |
| 汇率变动对现金及现金等价物的影响 | -11,105.96 | -6,424.71 | -7,171.42 | -4,046.21 |
| 现金及现金等价物净增加额 | 192,644,759.98 | 45,209,949.43 | 22,200,691.97 | 8,813,154.69 |
| 期末现金及现金等价物余额 | 312,707,738.76 | 165,272,928.21 | 120,062,978.78 | 106,675,441.5 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 192,644,759.98 | - | 22,200,691.97 | - |
最新报告期：2026-08-31| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 西南证券 | 杜向阳 | 0.84 | 1.00 | 1.20 | 2026-08-31 |
| 开源证券 | 阮帅,余汝意 | 0.86 | 1.04 | 1.24 | 2026-08-28 |